Pacer Advisors’s Arcosa ACA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,560
Closed -$120K 3407
2025
Q1
$120K Buy
+1,560
New +$143K ﹤0.01% 1936
2021
Q1
Sell
-14,509
Closed -$797K 1522
2020
Q4
$797K Buy
14,509
+4,155
+40% +$212K 0.02% 793
2020
Q3
$457K Buy
10,354
+2,778
+37% +$122K 0.01% 1011
2020
Q2
$320K Buy
7,576
+478
+7% +$18.4K 0.01% 775
2020
Q1
$294K Sell
7,098
-4,771
-40% -$202K 0.01% 321
2019
Q4
$529K Buy
11,869
+417
+4% +$16K 0.02% 766
2019
Q3
$392K Buy
+11,452
New +$396K 0.01% 1034
2019
Q1
Sell
-10,793
Closed -$299K 742
2018
Q4
$299K Buy
+10,793
New +$297K 0.01% 189

Other funds holding ACA

Pacer Advisors's ACA Position: Q2 2025 in Review

Pacer Advisors sold out of Arcosa (ACA) in Q2 2025, closing a stake of 1,560 shares — an estimated $120K sold.

Pacer Advisors first reported a position in ACA in Q4 2018 and held it in 8 quarters. The position peaked at $797K in Q4 2020. 329 funds tracked by Wall St. Rank hold ACA as of Q2 2025.

  • Pacer Advisors reported no remaining Arcosa position as of Q2 2025 after selling out during the quarter.
  • Pacer Advisors sold 1,560 Arcosa shares in Q2 2025, an estimated $120K.
  • Pacer Advisors first reported a position in Arcosa in Q4 2018 and held it in 8 quarters.
  • Pacer Advisors's Arcosa position peaked at $797K in Q4 2020.
  • 329 funds tracked by Wall St. Rank held Arcosa as of Q2 2025.

Based on Pacer Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.